| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 01/26/2005 | CN1186454C Mannose quantitatively determining method and reagent thereof |
| 01/25/2005 | US6847898 Real time determination of gas solubility and related parameters in manufacturing processes |
| 01/25/2005 | US6847897 Method and system for analyzing biological response signal data |
| 01/25/2005 | US6847835 Transcutaneous bilirubin concentration measuring apparatus and a measurement data checking plate for use with the same |
| 01/25/2005 | US6847746 Optical waveguide type microplate |
| 01/25/2005 | US6847451 Apparatuses and methods for analyte concentration determination |
| 01/25/2005 | US6847447 Apparatus and method and techniques for measuring and correlating characteristics of fruit with visible/near infra-red spectrum |
| 01/25/2005 | US6847216 Method and apparatus for stabilizing parasitic error capacitance in oil quality sensors |
| 01/25/2005 | US6847033 Method and device for quickly and continually detecting changes in the concentration of radon gas that is dissolved in water |
| 01/25/2005 | US6846920 Comprises nucleotide sequences coding eosinophil protease (EOS) for preparing laundry detergents, stain-removing solutions, skin care products and treating blood and respiratory system disorders |
| 01/25/2005 | US6846919 Non-endogenous, constitutively activated human serotonin receptors and small molecule modulators thereof |
| 01/25/2005 | US6846912 Monoclonal antibody specific for leukocyte antigen related (LAR) phosphatase for diagnosis and treatment of thyroid cancer insulin resistance and arteriosclerosis |
| 01/25/2005 | US6846911 An isolated protein comprising a soluble CD97 alpha subunit, and soluble subunit is selected from the group alpha 1, alpha 2, and alpha 3, originate as proprotein with beta subunit |
| 01/25/2005 | US6846908 DCR-5 bone affecting ligand |
| 01/25/2005 | US6846907 Osteoporosis treatment |
| 01/25/2005 | US6846906 Modified proteins of the TGF-β superfamily, including morphogenic proteins |
| 01/25/2005 | US6846905 Antigen constructs useful in the detection and differentiation of antibodies to HIV |
| 01/25/2005 | US6846819 Bactericides compound containing acrylamide group |
| 01/25/2005 | US6846804 Affinity tag of a sublancin peptide variant having a Gly-His peptide sequence fused to the C-terminal end of the mature sublancin peptide |
| 01/25/2005 | US6846803 Hybrid polynucleotide |
| 01/25/2005 | US6846799 Administering epidermal growth factor antagonist; blocking with antibody; chronic obstructive pulmonary disease |
| 01/25/2005 | US6846679 Characterizing polypeptides through cleavage and mass spectrometry |
| 01/25/2005 | US6846675 Skin substitutes and uses thereof |
| 01/25/2005 | US6846668 Apparatus comprising conduits and needle for transfer of fluids and small articles into cells; microinjection and agrochemicals/semiconuctors |
| 01/25/2005 | US6846667 Virulence genes and proteins, and their use |
| 01/25/2005 | US6846654 Catalytic antibodies as chemical sensors |
| 01/25/2005 | US6846650 Nucleotide sequences coding polypeptide for use in the imaging, diagnosis, treatment classification and prevention of lung cancer |
| 01/25/2005 | US6846648 Identifying parasites in bodily fluids using retenion flters and binding agents |
| 01/25/2005 | US6846645 Multiplexed enzymatic assays |
| 01/25/2005 | US6846643 Methods and molecules useful for identifying molecules that bind LFA-1 and for determining receptor occupancy |
| 01/25/2005 | US6846642 Methods of detecting cancer based on prostasin |
| 01/25/2005 | US6846641 Useful for analysis of mechanisms of cell death following brain ischemia, screening anti-ischemic drugs |
| 01/25/2005 | US6846640 Identifying modulators of polypeptide aggregation; for treating alzheimer's, down's syndrome, huntington's, parkinson's, prion, amyotrophic lateral sclerosis, lewy bodies and/or diabetic diseases |
| 01/25/2005 | US6846639 Detecting parasites attached to preferential antibodies; provide fluidic channel with electrodes, deposit antibodies on electrode, apply current, measure adjustment in impedance, adjsutment in impedance indicates parasite |
| 01/25/2005 | US6846638 Method and system for rapid biomolecular recognition of amino acids and protein sequencing |
| 01/25/2005 | US6846635 Multicompartment assay comprising immobilized fibers of variable length; solid phase immunoassays |
| 01/25/2005 | US6846634 Method to screen phage display libraries with different ligands |
| 01/25/2005 | US6846629 Methods and apparatus for improved luminescence assays using microparticles |
| 01/25/2005 | US6846627 Screening for novel compounds which regulate biological interactions |
| 01/25/2005 | US6846625 Method for identifying validated target and assay combination for drug development |
| 01/25/2005 | US6846623 LGMD gene coding for a calcium dependent protease |
| 01/25/2005 | US6846453 Detecting concentration in sample; quantitative analysis; radiation transparent window |
| 01/25/2005 | US6846281 Bio cell cleaning centrifuge having detachable chamber body |
| 01/25/2005 | US6846028 Dual function bailer |
| 01/25/2005 | US6845654 Method for measuring the surface tension of an aqueous solution |
| 01/25/2005 | CA2161084C Surface amplifier |
| 01/25/2005 | CA2155756C Borrelia burgdorferi spirochete specific nucleic acid probes |
| 01/25/2005 | CA2123224C Murine monoclonal antibody (5c8) recognizes a human glycoprotein on the surface of t-lymphocytes |
| 01/22/2005 | CA2474579A1 Detecting soot during real time operation in diesel engine lubricant |
| 01/20/2005 | WO2005006236A2 System and method for scoring peptide mass fingerprinting |
| 01/20/2005 | WO2005005991A1 Device and method for simultaneously identifying blood group antigens |
| 01/20/2005 | WO2005005990A2 Inverse labeling method for the rapid identification of marker target proteins |
| 01/20/2005 | WO2005005989A1 A method for predicting the metastatic potential of breast cancer |
| 01/20/2005 | WO2005005988A2 Dosing teichoic acids of gram+ bacteria |
| 01/20/2005 | WO2005005987A1 Diagnostic test |
| 01/20/2005 | WO2005005986A1 Device and method for simultaneous carrying out of blood group determination, serum cross-check and antibody detection test |
| 01/20/2005 | WO2005005985A1 Device and method for the direct quantitative in vitro determination of a substance that is contained in a sample |
| 01/20/2005 | WO2005005984A1 Method of diagnosing disease relating to endometriosis |
| 01/20/2005 | WO2005005983A1 Method of diagnosing disease relating to endometriosis |
| 01/20/2005 | WO2005005982A1 Polydiacetylene-containing solid colorimetric and/or fluorescent detector, method for its preparation and uses thereof |
| 01/20/2005 | WO2005005981A2 Bio-electrochemical process for producing hydrogen |
| 01/20/2005 | WO2005005980A2 Methods for tumor evaluation, identification of anti-tumor agents and treatment |
| 01/20/2005 | WO2005005979A1 Label-free method for classification and characterization of cellular events |
| 01/20/2005 | WO2005005978A2 Fluorine nmr spectroscopy for biochemical screening |
| 01/20/2005 | WO2005005977A2 Fluorescent phospholipase assays and compositions |
| 01/20/2005 | WO2005005974A1 Structure and manufacturing method of disposable electrochemical sensor strip |
| 01/20/2005 | WO2005005973A1 Improved electrodes |
| 01/20/2005 | WO2005005970A1 Type identification system for diesel oil and method for identifying type of diesel oil |
| 01/20/2005 | WO2005005966A2 Device for lateral flow tests |
| 01/20/2005 | WO2005005962A1 Inspection system for detecting explosives |
| 01/20/2005 | WO2005005960A2 High throughput one-hybrid system |
| 01/20/2005 | WO2005005957A2 Method of detecting cancer using delta-catenin |
| 01/20/2005 | WO2005005956A2 Fluorophore compounds and their use in biological systems |
| 01/20/2005 | WO2005005955A2 Specific detection of chitin using chitin-binding domain |
| 01/20/2005 | WO2005005954A2 Method, composition and kit for detecting phosphatidylserine (ps) on cell membranes |
| 01/20/2005 | WO2005005951A2 Fluidic force discrimination |
| 01/20/2005 | WO2005005933A1 Method of marking a product, marked product resulting thereof, and method of identifying same |
| 01/20/2005 | WO2005005665A1 Method of evaluating compound efficacious in treating obesity |
| 01/20/2005 | WO2005005664A1 Method of detecting and method of identifying nucleic acid |
| 01/20/2005 | WO2005005657A1 Protease detection assay |
| 01/20/2005 | WO2005005636A1 IgM PRODUCTION BY TRANSFORMED CELL AND METHOD OF QUANTIFYING THE SAME |
| 01/20/2005 | WO2005005611A2 Crystals and structures of protein kinase chk2 |
| 01/20/2005 | WO2005005602A2 Methods for the identification of inhibitors of fumarate reductase and vacuolar protein sorting-associated protein as antibiotics |
| 01/20/2005 | WO2005005601A2 Compositions and methods for treating and diagnosing cancer |
| 01/20/2005 | WO2005005483A1 Emitter-binding peptides causing a change in the spectral emission properties of the emitter |
| 01/20/2005 | WO2005005482A1 Emitter-binding peptides, which cause a modification of the spectral emission characteristics of the emitter |
| 01/20/2005 | WO2005005478A2 Diagnostics and therapeutics for diseases associated with g protein-coupled opioid receptor; delta 1 (oprd1) |
| 01/20/2005 | WO2005005468A1 Novel hcv core+1 protein, methods for diagnosis of hcv infections, prophylaxis, and for screening of anti-hcv agents |
| 01/20/2005 | WO2005005401A1 Sulfonic ester compound and fluorescent probe employing the same |
| 01/20/2005 | WO2005005385A1 Novel chemiluminescent compounds and their use |
| 01/20/2005 | WO2005005039A1 Methods for producing ligand arrays |
| 01/20/2005 | WO2005004988A2 Compositions and methods relating to novel compounds and targets thereof |
| 01/20/2005 | WO2005004905A1 Use of calpain for identifying compounds that modulate pain |
| 01/20/2005 | WO2005004883A2 Compound testing method |
| 01/20/2005 | WO2005004800A2 Trypanosome derived apoptotic factors (taf) |
| 01/20/2005 | WO2005004798A2 Methods for treating lentivirus infections |
| 01/20/2005 | WO2005004793A2 Compositions and methods for treating coagulation related disorders |
| 01/20/2005 | WO2005004591A1 Treatment models and uses thereof |
| 01/20/2005 | WO2004106411A3 Biodegradable poly(beta-amino esters) and uses thereof |
| 01/20/2005 | WO2004106385A3 Monoclonal antibodies specific for buprenorphine and metabolites thereof |